Fieldpoint Private Securities’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$3K Sell
31
-247
-89% -$25.6K ﹤0.01% 1038
2022
Q1
$31K Sell
278
-324
-54% -$38K 0.01% 712
2021
Q4
$73K Sell
602
-133
-18% -$14.8K 0.01% 497
2021
Q3
$74K Sell
735
-65
-8% -$7.17K 0.02% 480
2021
Q2
$92K Buy
800
+135
+20% +$16.2K 0.02% 435
2021
Q1
$73K Buy
665
+540
+432% +$58.6K 0.02% 471
2020
Q4
$13K Buy
+125
New +$11.6K ﹤0.01% 815
2020
Q1
Sell
-488
Closed -$39K 342
2019
Q4
$39K Buy
488
+232
+91% +$17.8K 0.01% 476
2019
Q3
$19K Buy
+256
New +$18.4K 0.01% 519

Other funds holding EMN

Fieldpoint Private Securities's EMN Position: Q2 2022 in Review

Fieldpoint Private Securities reduced its Eastman Chemical (EMN) stake by 89% in Q2 2022, selling an estimated $25.6K and leaving 31 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #1038.

Fieldpoint Private Securities first reported a position in EMN in Q3 2019 and has held it in 9 quarters since. The position peaked at $92K in Q2 2021. 688 funds tracked by Wall St. Rank hold EMN as of Q2 2022.

  • Fieldpoint Private Securities held 31 shares of Eastman Chemical worth $3K as of Q2 2022.
  • Fieldpoint Private Securities sold 247 Eastman Chemical shares in Q2 2022, an estimated $25.6K.
  • Eastman Chemical made up ﹤0.01% of Fieldpoint Private Securities's portfolio in Q2 2022, its #1038 holding.
  • Fieldpoint Private Securities first reported a position in Eastman Chemical in Q3 2019 and has held it in 9 quarters since.
  • Fieldpoint Private Securities's Eastman Chemical position peaked at $92K in Q2 2021.
  • 688 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2022.

Based on Fieldpoint Private Securities's 13F filing for Q2 2022, filed 5 Aug 2022.